References
- 1. Bãcanu E, Lixandru D, Serafinceanu C. The Association Between Adipokines, insulin resistance markers and microalbuminuria in obese Type 2 diabetic patients. Acta Endocrinol. 2014:228-37.10.4183/aeb.2014.228
- 2. Popa S, Mota M, Popa A, Mota E, Serafinceanu C, Guja C, et al. Prevalence of overweight/obesity, abdominal obesity and metabolic syndrome and atypical cardiometabolic phenotypes in the adult Romanian population: PREDATORR study. J Endocrinol Invest. 2016;39(9):1045-53.10.1007/s40618-016-0470-427126310
- 3. Ganz ML, Wintfeld N, Li Q, Alas V, Langer J, Hammer M. The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. Diabetology & Metabolic Syndrome. 2014;6(1):50.10.1186/1758-5996-6-50397645824694251
- 4. Barnes AS. The epidemic of obesity and diabetes: trends and treatments. Tex Heart Inst J. 2011;38(2):142-4.
- 5. Afshin A, Sur PJ, Fay KA, Cornaby L, Ferrara G, Salama JS, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2019;393(10184):1958-72.10.1016/S0140-6736(19)30041-8689950730954305
- 6. Constandache M, Nenciu DS. The Structure Of Romanian’s Food Consumption and its Implications on Health Condition and Quality Of Life. Romanian Statistical Review. 2013;61(12):41-51.
- 7. Dumitru E, Condur L, Alexandrescu L, Chirila S, Greere M, Radu C, et al. Triple Antioxidant Therapy, an Alternative for Patients with Chronic Liver Disease - A Prospective Multicenter Interventional Study. Maedica (Bucur). 2020;15(4):433-9.